Becton, Dickinson and Company (LON:0R19)
| Market Cap | 41.67B |
| Revenue (ttm) | 16.25B |
| Net Income (ttm) | 1.25B |
| Shares Out | n/a |
| EPS (ttm) | 4.33 |
| PE Ratio | 33.38 |
| Forward PE | 13.02 |
| Dividend | 3.13 (1.60%) |
| Ex-Dividend Date | Dec 8, 2025 |
| Volume | 4,153 |
| Average Volume | 2,445 |
| Open | 195.27 |
| Previous Close | 194.33 |
| Day's Range | 192.62 - 196.64 |
| 52-Week Range | 162.29 - 251.08 |
| Beta | 0.30 |
| RSI | 55.51 |
| Earnings Date | Feb 5, 2026 |
About LON:0R19
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. It operates through Medical Essentials, Connected Care, BioPharma Systems, Interventional and Life Sciences segments. It provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, va... [Read more]
Financial Performance
In 2025, LON:0R19's revenue was $21.84 billion, an increase of 8.24% compared to the previous year's $20.18 billion. Earnings were $1.68 billion, a decrease of -1.58%.
Financial numbers in USD Financial StatementsNews
BD and Penn Institute for Immunology and Immune Health Collaborate to Advance Immunotherapy through Flow Cytometry
BD FACSDiscover™ A8 Cell Analyzer to Enable Investigation of 30+ Cellular Characteristics to Capture Key Biological Insights and Support Planned 1,000-Person Immune Profiling Study FRANKLIN LAKES, N.J...
Insider Sell: Michael Garrison Sells Shares of Becton Dickinson & Co (BDX)
Insider Sell: Michael Garrison Sells Shares of Becton Dickinson & Co (BDX)
The Magnificent 7 Are So Yesterday. These Are AI's Next Big Winners
Today I have a sweet dividend “double shot” for you: The first? A 2.8% payout set to grow thanks to AI—and take the stock price up with it.
RBC Capital Raises Becton Dickinson (BDX) Price Target to $210 | BDX Stock News
RBC Capital Raises Becton Dickinson (BDX) Price Target to $210 | BDX Stock News
BD Expands BD MAX™ System Menu with New IVDR-Certified VIASURE Assays in Partnership with Certest Biotec
FRANKLIN LAKES, N.J. , Dec. 15, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the expansion of its respiratory and s...
YieldBoost BDX From 2.1% To 5.9% Using Options
Shareholders of Becton, Dickinson & Co (Symbol: BDX) looking to boost their income beyond the stock's 2.1% annualized dividend yield can sell the January 2028 covered call at the $240 strike and colle...
Becton, Dickinson Reaches Analyst Target Price
In recent trading, shares of Becton, Dickinson & Co (Symbol: BDX) have crossed above the average analyst 12-month target price of $200.40, changing hands for $200.43/share. When a stock reaches the ta...
BDX Makes Notable Cross Below Critical Moving Average
In trading on Monday, shares of Becton, Dickinson & Co (Symbol: BDX) crossed below their 200 day moving average of $191.25, changing hands as low as $189.50 per share. Becton, Dickinson & Co shares ar...
Noteworthy Thursday Option Activity: COHR, RGTI, BDX
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Coherent Corp (Symbol: COHR), where a total of 24,414 contracts have traded so far, represe...
Ex-Dividend Reminder: Becton, Dickinson, Nicolet Bankshares and UnitedHealth Group
Looking at the universe of stocks we cover at Dividend Channel, on 12/8/25, Becton, Dickinson & Co (Symbol: BDX), Nicolet Bankshares Inc (Symbol: NIC), and UnitedHealth Group Inc (Symbol: UNH) will al...
BD and ChemoGLO™ Collaborate to Expand Hazardous Drug Contamination Testing for Health Care Facilities and Laboratories
FRANKLIN LAKES, N.J. , Dec. 4, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and ChemoGLO™, a specialist in hazardous drug detection...
BD Launches New Cell Analyzer Configurations to Bring Cutting-Edge Capabilities to Labs of All Sizes
Three- and Four-Laser BD FACSDiscover™ A8 Cell Analyzers Expand Accessibility of Spectral, Real-Time Imaging Cell Analysis FRANKLIN LAKES, N.J. , Dec. 3, 2025 /PRNewswire/ -- BD (Becton, Dickinson and...
Insider Sell: Michael Feld Sells Shares of Becton Dickinson & Co (BDX)
Insider Sell: Michael Feld Sells Shares of Becton Dickinson & Co (BDX)
BDX: Morgan Stanley Raises Price Target on Becton Dickinson | BDX Stock News
BDX: Morgan Stanley Raises Price Target on Becton Dickinson | BDX Stock News
Best Dividend Aristocrats For December 2025
The ProShares S&P 500 Dividend Aristocrats ETF (NOBL) has underperformed the SPDR S&P 500 ETF (SPY) year-to-date, but November shows a reversal. Several Dividend Aristocrats, including CAH, CAT, CHRW,...
Beyond the Balance Sheet: What SWOT Reveals About Becton Dickinson & Co (BDX)
Beyond the Balance Sheet: What SWOT Reveals About Becton Dickinson & Co (BDX)
TCAF, BDX, CNP, NI: ETF Outflow Alert
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the T. Rowe Price Capital Appreciation Equity ETF (Symbol: TCAF) where we ...
BD Launches Surgiphor Surgical Wound Irrigation System In Europe
(RTTNews) - Becton, Dickinson and Company (BDX), a medical technology company, said Monday that it has launched the BD Surgiphor Surgical Wound Irrigation System in Europe. The system is now available...
BD Surgiphor™ Surgical Wound Irrigation System Expands to Europe to Help Hospitals Improve Patient Safety
FRANKLIN LAKES, N.J. , Nov. 24, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the launch of the BD Surgiphor™ Surgic...
How Do Investors Really Feel About Becton Dickinson & Co?
Becton Dickinson & Co's (NYSE: BDX) short interest as a percent of float has fallen 5.31% since its last report. According to exchange reported data, there are now 3.11 million shares sold short , wh...
Becton, Dickinson (BDX) Gains Favor with 1578 Partners Amid Portfolio Shifts
Becton, Dickinson (BDX) Gains Favor with 1578 Partners Amid Portfolio Shifts
Becton, Dickinson: Our New, Long, Special Situation Investment
Becton, Dickinson and Company (BDX) Expands Board with Two New Appointments
Becton, Dickinson and Company (BDX) Expands Board with Two New Appointments
BD Appoints Robert Huffines and Jacqueline Wright to Board of Directors
FRANKLIN LAKES, N.J. , Nov. 17, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the appointment of Robert "Robbie" Huf...
Becton, Dickinson And Company's BD Onclarity HPV Assay Secures Acceptance To WHO Prequalified List
(RTTNews) - Becton, Dickinson and Company (BDX), Monday the Conformite Europeenne or CE Marked BD Onclarity HPV Assay for the BD COR System and the BD Viper LT System have been accepted for the World ...